Similar articles

• Aerosol treatment of pigs with Actinobacillus pleuropneumoniae serotype 2: mucosal immunity and resistance against challenge.

  Loftager MK, Eriksen L, Nielsen R. Loftager MK, et al. Adv Exp Med Biol. 1995;371B:1611-4. Adv Exp Med Biol. 1995. PMID: 7502867 No abstract available.
• Protective immunity following immunisation of pigs with aerosol of Actinobacillus pleuropneumoniae serotype 2.

  Loftager MK, Eriksen L, Aasted B, Nielsen R. Loftager MK, et al. Res Vet Sci. 1993 Nov;55(3):281-6. doi: 10.1016/0034-5288(93)90095-w. Res Vet Sci. 1993. PMID: 8284489
• Immunization by the enteral and respiratory route with viable and inactivated bacteria results in a differential increase in lymphocyte subsets in the bronchoalveolar space.

  Pabst R, Delventhal S, Hensel A, Petzoldt K. Pabst R, et al. Adv Exp Med Biol. 1995;371B:1459-61. Adv Exp Med Biol. 1995. PMID: 7502837 No abstract available.
• Induction of protective immunity by aerosol or oral application of candidate vaccines in a dose-controlled pig aerosol infection model.

  Hensel A, van Leengoed LA, Szostak M, Windt H, Weissenböck H, Stockhofe-Zurwieden N, Katinger A, Stadler M, Ganter M, Bunka S, Pabst R, Lubitz W. Hensel A, et al. J Biotechnol. 1996 Jan 26;44(1-3):171-81. doi: 10.1016/0168-1656(95)00150-6. J Biotechnol. 1996. PMID: 8717401 Review.
• Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.

  Dubreuil JD, Jacques M, Mittal KR, Gottschalk M. Dubreuil JD, et al. Anim Health Res Rev. 2000 Dec;1(2):73-93. doi: 10.1017/s1466252300000074. Anim Health Res Rev. 2000. PMID: 11708600 Review.